Article Text

Download PDFPDF

Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
  1. C De Bac,
  2. F Grimaldi,
  3. C Clementi,
  4. F Duca,
  5. D Livoli,
  6. G Taliani
  1. Viral Hepatology Service, La Sapienza University, Rome, Italy.


    Four different dosage regimens of interferon (IFN) alfa-2b (3 million units (MU) three times weekly for three months, 3 MU three times weekly for six months, 6 MU two times weekly for six months, and 6 MU three times weekly for six months) were compared in patients with chronic hepatitis C. There was no significant difference measured by percentage of responders to treatment between the four groups, but the degree of response was inversely correlated with the severity of liver damage. Viraemia was undetectable in most (75%) of responders treated with interferon and also in 20% of those who did not respond to treatment.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.